Anja Oštrbenk Valenčak

4PUBLICATIONS
28CO-AUTHORS
Predictive and prognostic markersCancer diagnosisPsychosocial aspects of childbirth and perinatal mental health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Oct 13, 2026
The Role of Methylation Marker FAM19A4/mir124-2 and HPV Genotype in Active Surveillance of Women With Cervical Intraepithelial Neoplasia Grade 2 (CIN2).

|Apr 25, 2026
International Collaborative Study on Human Papillomavirus Analytical Thresholds for Sensitivity and Specificity in Cervical Screening.

|Sep 24, 2024
Clinically validated HPV assays offer comparable long-term safety in primary cervical cancer screening: A 9-year follow-up of a population-based screening cohort.

Anja Oštrbenk Valenčak, Kelsi R Kroon, Danijela Fabjan

|Jun 10, 2022
FAM19A4/miR124-2 Methylation Testing and Human Papillomavirus (HPV) 16/18 Genotyping in HPV-Positive Women Under the Age of 30 Years.

Frederique J Vink, Chris J L M Meijer, Albertus T Hesselink

Pageof 1

Frequent Collaborators

3 joint publications

Mario Poljak

1 joint publications

Emel Yilmaz

1 joint publications

Davy Vanden Broeck

1 joint publications

Jean-Luc Prétet